Reply: Potential risk associated with direct modulation of the gut flora in patients with heart failure

por Mayerhofer, Cristiane C.K., Awoyemi, Ayodeji, Hov, Johannes R., Trøseid, Marius, Broch, Kaspar
Publicado 2019

Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure

por Nendl, Andraž, Raju, Sajan C., Broch, Kaspar, Mayerhofer, Cristiane C. K., Holm, Kristian, Halvorsen, Bente, Lappegård, Knut Tore, Moscavitch, Samuel, Hov, Johannes Roksund, Seljeflot, Ingebjørg, Trøseid, Marius, Awoyemi, Ayodeji
Publicado 2023

Design of the GutHeart—targeting gut microbiota to treat heart failure—trial: a Phase II, randomized clinical trial

por Mayerhofer, Cristiane C.K., Awoyemi, Ayodeji O., Moscavitch, Samuel D., Lappegård, Knut Tore, Hov, Johannes R., Aukrust, Pål, Hovland, Anders, Lorenzo, Andrea, Halvorsen, Sigrun, Seljeflot, Ingebjørg, Gullestad, Lars, Trøseid, Marius, Broch, Kaspar
Publicado 2018

Low fibre intake is associated with gut microbiota alterations in chronic heart failure

por Mayerhofer, Cristiane C.K., Kummen, Martin, Holm, Kristian, Broch, Kaspar, Awoyemi, Ayodeji, Vestad, Beate, Storm‐Larsen, Christopher, Seljeflot, Ingebjørg, Ueland, Thor, Bohov, Pavol, Berge, Rolf K., Svardal, Asbjørn, Gullestad, Lars, Yndestad, Arne, Aukrust, Pål, Hov, Johannes R., Trøseid, Marius
Publicado 2020

Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial

por Awoyemi, Ayodeji, Mayerhofer, Cristiane, Felix, Alex S, Hov, Johannes R, Moscavitch, Samuel D, Lappegård, Knut Tore, Hovland, Anders, Halvorsen, Sigrun, Halvorsen, Bente, Gregersen, Ida, Svardal, Asbjørn, Berge, Rolf K, Hansen, Simen H, Götz, Alexandra, Holm, Kristian, Aukrust, Pål, Åkra, Sissel, Seljeflot, Ingebjørg, Solheim, Svein, Lorenzo, Andrea, Gullestad, Lars, Trøseid, Marius, Broch, Kaspar
Publicado 2021